Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study

Autor: Tarun Bhatnagar, Sirshendu Chaudhuri, Manickam Ponnaiah, Pragya D Yadav, R Sabarinathan, Rima R Sahay, Faheem Ahmed, S Aswathy, Pankaj Bhardwaj, Anil Bilimale, M Santhosh Kumar, M. Logaraj, Uday Narlawar, C Palanivel, Prakash Patel, Sanjay K Rai, Vartika Saxena, Arvind Singh, Jeromie WV Thangaraj, Ashwini Agarwal, Yasir Alvi, Amoghashree, P Ashok, Dinesh Babu, Yogesh Bahurupi, Sangita Bhalavi, Priyamadhaba Behera, Priyanka Pandit Biswas, Jaykaran Charan, Nishant Kumar Chauhan, KB Chetak, Lalit Dar, Ayan Das, R Deepashree, Minakshi Dhar, Rahul Dhodapkar, TS Dipu, Mridu Dudeja, Manisha Dudhmal, Ravisekhar Gadepalli, Mahendra Kumar Garg, AV Gayathri, Akhil Dhanesh Goel, H Basavana Gowdappa, Randeep Guleria, Manoj Kumar Gupta, Farzana Islam, Mannu Jain, Vineet Jain, M Lanord Stanley Jawahar, Rajendra Joshi, Shashi Kant, Sitanshu Sekhar Kar, Deepjyoti Kalita, Meenakshi Khapre, Satyendra Khichar, Sarika Prabhakar Kombade, Sunil Kohli, Abhinendra Kumar, Anil Kumar, Deepak Kumar, Kiran G Kulirankal, KV Leela, Triparna Majumdar, Baijayantimala Mishra, Puneet Misra, Sanjeev Misra, Prasanta Raghab Mohapatra, M Narayana Murthy, Dimpal A Nyayanit, Manish Patel, Monika Pathania, Savita Patil, Binod Kumar Patro, Ramniwas Jalandra, Pragati Rathod, Naimesh Shah, Anita Shete, Deepak Shukla, M Shwethashree, Smita Sinha, MN Sumana, Ashish Surana, Anjan Trikha, A Tejashree, Mahalingam Venkateshan, G Vijaykrishnan, Sarita Wadhava, Naveet Wig, Nivedita Gupta, Priya Abraham, Manoj V Murhekar

Publikováno v: International Journal of Infectious Diseases, Vol 122, Iss , Pp 693-702 (2022)

Objectives: India introduced BBV152/Covaxin and AZD1222/Covishield vaccines in January 2021. We estimated the effectiveness of these vaccines against severe COVID-19 among individuals aged ≥45 years. Methods: We did a multi-centric, hospital-based,

Externí odkaz: https://doaj.org/article/ae9a4d01bbc948f5903a25216c64b295

Effectiveness of BBV152/Covaxin and AZD1222/Covishield Vaccines Against Severe COVID-19 and B.1.617.2/Delta Variant in India, 2021: A Multi-Centric Hospital-Based Case-Control Study

Autor: Farzana Islam, Ayan Das, Triparna Majumdar, Arvind Kumar Singh, M Shwethashree, Manickam Ponnaiah, KV Leela, Satyendra Khichar, S Aswathy, R. Sabarinathan, Ashish Surana, Binod Kumar Patro, Yogesh Bahurupi, Sanjay K Rai, Deepak Kumar, C. Palanivel, Anjan Trikha, Baijayantimala Mishra, TS Dipu, Pragati Rathod, Manoj Kumar Gupta, Kiran G. Kulirankal, Vartika Saxena, Ramniwas Jalandra, Sarika P Kombade, Prakash Patel, AV Gayathri, Nishant Kumar Chauhan, Shashi Kant, Tarun Bhatnagar, Sangita Bhalavi, Mannu Jain, Prasanta Raghab Mohapatra, Priya Abraham, Santhosh Kumar Muthusamy, Pankaj Bhardwaj, Vineet Jain, Dinesh Babu, Ashwini Agarwal, Naveet Wig, Puneet Misra, R Deepashree, Smita Sinha, Rima R Sahay, Pragya D Yadav, Amoghashree, Manoj V Murhekar, Dimpal A Nyayanit, Priyanka Pandit Biswas, Lalit Dar, M R Narayana Murthy, Rajendra Joshi, Meenakshi Khapre, Sitanshu Sekhar Kar, Sanjeev Misra, Basavana Gowdappa, Mahendra Kumar Garg, Rahul Dhodapkar, KB Chetak, Minakshi Dhar, M Logaraj, Sarita Wadhava, Abhinendra Kumar, Manish Patel, Deepak Shukla, Naimesh Shah, Ravisekhar Gadepalli, Priyamadhaba Behera, Faheem Ahmed, Jaykaran Charan, Mahalingam Venkateshan, Deepjyoti Kalita, M. Lanord Stanley Jawahar, Mridu Dudeja, Nivedita Gupta, P Ashok, Randeep Guleria, Akhil Dhanesh Goel, Yasir Alvi, Anita M. Shete, Uday Wasudeorao Narlawar, G Vijaykrishnan, Savita Patil, A Tejashree, Manisha Dudhmal, Sunil Kohli, Monika Pathania, Anil Kumar, Anil S. Bilimale, Jeromie Wesley Vivian Thangaraj, Sirshendu Chaudhuri

Publikováno v: SSRN Electronic Journal.

Background: India introduced BBV152/Covaxin and AZD1222/Covishield vaccines from January 2021. We estimated effectiveness of these vaccines against severe Coronavirus disease 2019 (COVID-19) among individuals aged >=45 years. Methods: We did a multi-

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8895ab60b0c6b34bb7badb0ce8536a5f
https://doi.org/10.2139/ssrn.3955739

Evaluation of Effect of Dietary Solvents on Bond Strength of Compomer, Ormocer, Nanocomposite and Activa Bioactive Restorative Materials

Autor: Sanjit Kumar, Sahoo, Ganesh R, Meshram, Anuj Singh, Parihar, Deepti, Pitalia, Hemjith, Vasudevan, Ashish, Surana

Publikováno v: Journal of International Society of Preventive & Community Dentistry

Objectives: The successful endodontic therapy is judged by ability of tooth to withstand masticatory forces. The present study focused on comparing the strength of restorative materials, i.e., compomer, ormocer, nanocomposite, and ACTIVA Bioactive af

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::b715fca7898296b4aec33c9ab6161575
https://pubmed.ncbi.nlm.nih.gov/31620377

The Appropriate DOTS Regimen Greatly Reduces the Disabilities in Polyarticular EPTB

Autor: Ashish Surana, Arvnd S. Pandey

Publikováno v: Journal of Clinical and Diagnostic Research, Vol 7, Iss 3, Pp 529-531 (2013)

The placement of cases of Extrapulmonary Tuberculosis (EPTB) on the appropriate Directly Observed Treatment Short Course (DOTS) regimen remains a problematic issue in India and often, consultants delay this, leading to significant avoidable pain, dis

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::002673fc08f8c5c0fc16d3c50dd929fc
https://europepmc.org/articles/PMC3616572/

Tuberculous osteomyelitis of the bone flap following craniotomy

Autor: Arvind S, Pandey, Ashish, Surana

Publikováno v: The Indian journal of tuberculosis. 58(3)

A patient of tuberculous osteomyelitis of the bone flap following craniotomy for acute subdural hemorrhage which was treated at Surat Municipal Institute of Medical EducationResearch (SMIMER) from June 2010 has been reported. This report emphasizes t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::87e78d7b2c4c3306d3133c8a072b7905
https://pubmed.ncbi.nlm.nih.gov/21941953